文献速递神经PETMR

基于11C-蛋氨酸整合PET/MRI的纹理分析特征可能具有区分少突胶质细胞瘤(IDH突变且1p/19q共缺失)与各类胶质瘤的潜在能力

11C-Methionine Integrated PET/MRI-Based Texture Analysis Features May Have a Potential Ability to Distinguish Oligodendroglioma (IDH-Mutant and 1p/19q-Codeleted) From Varied Gliomas.
PubMed 文献 · Acad Radiol · 2019-10-11

本研究回顾性分析70例胶质瘤患者的术前11C-蛋氨酸PET/MRI资料,评估纹理分析特征区分少突胶质细胞瘤(IDH突变且1p/19q共缺失)与其他胶质瘤的潜力。全队列中少突胶质细胞瘤的SUVmax、SUVmean及纹理特征(SD、中位数)较低;WHO II级亚组中纹理分析显示较高diffEntropy、diffVariance和熵。ROC分析提示部分常规和纹理特征的AUC范围为0.722至0.892,结论认为基于11C-蛋氨酸整合PET/MRI的纹理分析和常规特征可能是有前景的无创预测指标。

要点

  • 少突胶质细胞瘤(IDH突变且1p/19q共缺失)在全队列中SUVmax、SUVmean及纹理特征SD、中位数较低。
  • WHO II级亚组中常规特征无统计学差异,但纹理分析显示diffEntropy、diffVariance和熵较高。
  • 部分常规和纹理特征的AUC为0.722至0.892,提示对诊断有参考价值。

核心结论

  • 基于11C-蛋氨酸整合PET/MRI的纹理分析和常规特征可能是区分不同胶质瘤的有前景的无创预测指标。

研究设计与样本

  • 回顾性研究,纳入70例胶质瘤患者,术前行11C-蛋氨酸PET,术后行组织病理学分析(免疫组化检测IDH突变、聚合酶链反应分析、荧光毛细管电泳分析1p/19q共缺失),并进行纹理分析。

关键影像表现/征象

  • 全队列分析中,少突胶质细胞瘤(IDH突变且1p/19q共缺失)患者的SUVmax、SUVmean及纹理特征(SD和中位数)低于其他患者。
  • WHO II级亚组分析中,两组间常规特征无统计学差异。
  • WHO II级亚组中,少突胶质细胞瘤(IDH突变且1p/19q共缺失)患者的纹理分析显示较高的diffEntropy、diffVariance和熵。

诊断标准与关键数值

  • 全队列中,部分常规特征和纹理特征的AUC范围为0.722至0.892,对诊断有效。
  • WHO II级胶质瘤亚组分析中,部分常规特征和纹理特征的AUC范围为0.722至0.892,对诊断有效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Different histology and gene status of gliomas results in different natural history, treatment, and prognosis in different subgroups. Low-grade gliomas (LGGs) with isocitrate dehydrogenase (IDH) mutant and 1p/19q-codeleted are kind of gliomas with the most favorable outcome, reflecting operational strategy. Less invasive method for prediction of pathological type-even gene status-is desired.

MATERIALS AND METHODS: This study investigates the potential ability of methionine-positron emission tomography (MET-PET) to determine LGGs with IDH-mutant and 1p/19q-codeleted through a retrospective review of information of 70 glioma patients. Patients underwent preoperative MET-PET, followed by operation and histopathological analysis including Immunohistochemistry and polymerase chain reaction analysis for IDH-mutant and fluorescence capillary electrophoresis analysis for 1p/19q codeletion. Texture analysis was performed for further data mining. The t-test and receiver operating characteristic curve analysis were conducted for statistical analysis.

RESULTS: In the whole cohort analysis, SUVmax, SUVmean and texture features (SD and median) of oligodendroglioma, IDH-mutant and 1p/19q-codeleted patients were lower than these values of other patients. In WHO grade II subgroup analysis, no statistical difference of conventional features was observed between groups. Texture analysis displayed higher diffEntropy, diffVariance, and entropy in oligodendroglioma, IDH-mutant and 1p/19q-codeleted patients. Receiver operating characteristic analysis suggested AUCs of some conventional features and texture features ranged from 0.722 to 0.892 that are effective for diagnosis, determining LGGs with IDH-mutant and 1p/19q-codeleted in this cohort and WHO II grade glioma subgroup analysis respectively.

CONCLUSION: 11C-Methionine integrated PET/MRI based texture analysis and conventional features may be a promising noninvasive predictor for differentiating the varied gliomas.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhao K, Yu P, Xue Z, et al. 11C-Methionine Integrated PET/MRI-Based Texture Analysis Features May Have a Potential Ability to Distinguish Oligodendroglioma (IDH-Mutant and 1p/19q-Codeleted) From Varied Gliomas. Acad Radiol. 2019. PMID: 31607471. doi:10.1016/j.acra.2019.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。